Brain-derived neurotrophic factor (BDNF) polymorphisms G196A and C270T are not associated with response to electroconvulsive therapy in major depressive disorder

European Archives of Psychiatry and Clinical Neuroscience

Volumn 257, Issue 1, 2007, Pages 31-35

  Kaija, Huuhka ^a,b   Sami, Anttila ^a,b   Martti, Huuhka ^a,b   Esa, Leinonen ^a,b   Riikka, Rontu ^a,b   Kari, Mattila ^a,b   Terho, Lehtimäki ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

BDNF; Electroconvulsive therapy; Major depressive disorder; Polymorphism

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; FLUORESCENT DYE;

ADULT; ARTICLE; CONTROLLED STUDY; DEVICE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ELECTRIC CURRENT; ELECTROCONVULSIVE THERAPY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL PATIENT; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

AGE OF ONSET; ALLELES; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PSYCHIATRIC STATUS RATING SCALES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEX CHARACTERISTICS; TREATMENT OUTCOME;

EID: 33847126185     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-006-0679-x     Document Type: Article

References (43)

1. Duffy A, Grof P, Robertson C, Alda M (2000) The implications of genetics studies of major mood disorders for clinical practice. J Clin Psychiatry 61:630-637
2. American Psychiatric Association (2001) The practice of electroconvulsive therapy: recommendations for treatment, training and privileging: a task force report of the American Psychiatric Association. American Psychiatric Association, Washington, DC
3. Maisonpierre PC, Le Beau MM, Espinosa R 3rd, Ip NY, Belluscio L, de la Monte SM, Squinto S, Furth ME, Yancopoulos GD (1991) Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations. Genomics 10:558-568
4. Hashimoto K, Shimizu E, Iyo M (2004) Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Rev 45:104-114
5. Korte M, Carroll P, Wolf E, Brem G, Thoenen H, Bonhoeffer T (1995) Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci USA 92:8856-8860
6. Korte M, Griesbeck O, Gravel C, Carroll P, Staiger V, Thoenen H, Bonhoeffer T (1996) Virus-mediated gene transfer into hippocampal CA1 region restores long-term potentiation in brain-derived neurotrophic factor mutant mice. Proc Natl Acad Sci USA 93:12547-12552
7. Altar CA (1999) Neurotrophins and depression. Trends Pharmacol Sci 20:59-61
8. Smith MA, Makino S, Kvetnansky R, Post RM (1995) Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 15:1768-1777
9. Angelucci F, Aloe L, Vasquez PJ, Mathe AA (2000) Mapping the differences in the brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in an animal model of depression. Neuroreport 11:1369-1373
10. Okamoto H, Shino Y, Hashimoto K, Kumakiri C, Shimizu E, Shirasawa H, Iyo M (2003) Dynamic changes in AP-1 transcription factor DNA binding activity in rat brain following administration of antidepressant amitriptyline and brain-derived neurotrophic factor. Neuropharmacology 45:251-259
11. Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM (1997) Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 56:131-137
12. Duman RS (2004) Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med 5:11-25
13. Sheline YI (2003) Neuroimaging studies of mood disorder effects on the brain. Biol Psychiatry 54:338-352
14. Bielau H, Trübner K, Krell D, Agelink MW, Bernstein H-G, Stauch R, Mawrin C, Danos P, Gerhard L, Bogerts B, Baumann B (2005) Volume deficits of subcortical nuclei in mood disorders A postmortem study. Eur Arch Psychiatry Clin Neurosci 255:401-412
15. Duman RS, Vaidya VA (1998) Molecular and cellular actions of chronic electroconvulsive seizures. J ECT 14:181-193
16. Malberg JE, Eisch AJ, Nestler EJ, Duman RS (2000) Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20:9104-9110
17. Vaidya VA, Siuciak JA, Du F, Duman RS (1999) Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures. Neuroscience 89:157-166
18. Zetterstrom TS, Pei Q, Grahame-Smith DG (1998) Repeated electroconvulsive shock extends the duration of enhanced gene expression for BDNF in rat brain compared with a single administration. Brain Res Mol Brain Res 57:106-110
19. Altar CA, Laeng P, Jurata LW, Brockman JA, Lemire A, Bullard J, Bukhman YV, Young TA, Charles V, Palfreyman MG (2004) Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J Neurosci 24:2667-2677
20. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT (2001) Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 15(50):260-265
21. Gonul AS, Akdeniz F, Taneli F, Donat O, Eker C, Vahip S (2005) Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Arch Psychiatry Clin Neurosci 255:381-386
22. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112:257-269
23. Kunugi H, Iijima Y, Tatsumi M, Yoshida M, Hashimoto R, Kato T, Sakamoto K, Fukunaga T, Inada T, Suzuki T, Iwata N, Ozaki N, Yamada K, Yoshikawa T (2004) No association between the Val66Met polymorphism of the brain-derived neurotrophic factor gene and bipolar disorder in a Japanese population: a multicenter study. J Biol Psychiatry 56:376-378
24. Nakata K, Ujike H, Sakai A, Uchida N, Nomura A, Imamura T, Katsu T, Tanaka Y, Hamamura T, Kuroda S (2003) Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder. Neurosci Lett 337:17-20
25. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL (2002) The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorders: evidence from a family-based association study. Am J Hum Genet 71:651-655
26. Neves-Pereira M, Cheung JK, Pasdar A, Zhang F, Breen G, Yates P, Sinclair M, Crombie C, Walker N, St Clair DM (2005) BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry 10:208-212
27. Sklar P, Gabriel SB, McInnis MG, Bennett P, Lim Y-M, Tsan G, Schaffner S, Kirov G, Jones I, Owen M, Craddock N, De Paulo JR, Lander ES (2002) Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Mol Psychiatry 7:579-593
28. Hong C-J, Huo S-J, Yen F-C, Tung C-L, Pan G-M, Tsai S-J (2003) Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology 448:186-189
29. Tsai S-J, Cheng C-Y, Yu YW-Y, Chen T-J, Hong C-J (2003) Association study of a brain derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology and antidepressant response. Am J Med Gen 123B:19-22
30. Lam P, Cheng CY, Hong CJ, Tsai SJ (2004) Association study of a brain-derived neurotrophic factor (Val66Met) genetic polymorphism and panic disorder. Neuropsychobiology 49:178-181
31. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, (4th edn). American Psychiatric Press, Washington, DC
32. Swartz CM, Abrams R (1996) ECT Instruction manual, (6th edn). Somatic Inc., Lake Bluff, Illinois
33. Montgomery SA, Åsberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382-389
34. Folstein MF, Folstein SE, McHugh PR (1975) A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 14:189-198
35. Livak KJ (1999) Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 14:143-149
36. Kearns NP, Cruickshank CA, McGuigan KJ, Riley SA, Shaw SP, Snaith RP (1982) A comparison of depression rating scales. Br J Psychiatry 141:45-49
37. Fisman M, Rabheru K, Hegele RA, Sharma V, Fisman D, Doering M, Appell J (2001) Apolipoprotein E polymorphism and response to electroconvulsive therapy. J ECT 17:11-14
38. Krishnan KR, Tupler LA, Ritchie JC Jr, McDonald WM, Knight DL, Nemeroff CB, Carroll BJ (1996) Apolipoprotein E-epsilon 4 frequency in geriatric depression. Biol Psychiatry 4:69-71
39. Zupenko GS, Henderson R, Stiffler JS, et al. (1996) Association of the APOE, 4 allele with clinical subtypes of late life depression. Biol Psychiatry 40:1008-1016
40. Kanemoto K, Kawasaki J, Tarao Y, Kumaki T, Oshima T, Kaji R, Nishimura M (2003) Association of partial epilepsy with brain-derived neurotrophic factor (BDNF) gene polymorphisms. Epilepsy Res 53:255-258
41. Duman RS, Heninger GR, Nestler EJ (1997) A molecular and cellular theory of depression. Arch Gen Psychiatry 54:597-606
42. Schumacher J, Jamra RA, Becker T, Ohlraun S, Klopp N, Binder EB, Schulze TG, Deschner M, Schmäl C, Höfels S, Zobel A, Illig T, Propping P, Holsboer F, Rietscel M, Nöthen MM, Cichon S (2005) Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatry 58:307-314
43. Huuhka M, Anttila S, Leinonen E, Huuhka K, Rontu R, Mattila KM, Huhtala H, Lehtimaki T (2005) The apolipoprotein E polymorphism is not associated with response to electroconvulsive therapy in major depressive disorder. J ECT 21:7-11